All AbMole products are for research use only, cannot be used for human consumption.
Bendamustine hydrochloride (also known as SDX-105) is a DNA-damaging agent with IC50 of 50 μM. Bendamustine displays a distinct pattern of activity unrelated to other DNA-alkylating agents. Bendamustine hydrochloride activates a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Bendamustine hydrochloride (SDX-105) inhibits mitotic checkpoints and induces mitotic catastrophe. The combination of bendamustine with fludarabine led to a highly synergistic effect in inducing apoptosis, which was 150% higher than expected for bendamustine plus fludarabine. Bendamustine has been used both as sole therapy and in combination with other agents including etoposide, fludarabine, mitoxantrone, methotrexate, prednisone, rituximab and vincristine.
Molecular Weight | 394.72 |
Formula | C16H21Cl2N3O2.HCl |
CAS Number | 3543-75-7 |
Form | Solid |
Solubility (25°C) | DMSO 60 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related DNA Alkylator/Crosslinker Products |
---|
Illudin S
Illudin S, a cytotoxic Illudin, is a natural sesquiterpene with strong anti-tumour and antiviral activities. |
Illudin M
Illudin M is a cytotoxic fungal sesquiterpene that can be isolated from the culture medium of Omphalotus illudens mushrooms. |
Sibiromycin
Sibiromycin is a naturally produced glycosylated pyrrolobenzodiazepines (PBDs). |
Mitobronitol
Mitobronitol (Myelobromol; DBM) is a brominated analog of mannitol, also known as an anticancer agent that is classified as an alkylating agent. |
Duocarmycin analog-2
Duocarmycin analog-2 is a potent DNA alkylating agent. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.